Literature DB >> 2803289

Isolation and characterization of a tumor-derived human pancreastatin-related protein.

S Funakoshi1, H Tamamura, M Ohta, K Yoshizawa, A Funakoshi, K Miyasaka, K Tateishi, K Tatemoto, I Nakano, H Yajima.   

Abstract

A protein with pancreastatin-like immunoreactivity has been isolated and purified from liver metastasis of a patient with insulinoma. NH2-terminal sequence analysis in conjunction with the use of antibodies specific for the C-terminal structure of pancreastatin identified this protein as a 186-amino acid residue protein corresponding to human chromogranin A-116-301. Using a sensitive radioimmunoassay it was found that serum from the patient with insulinoma contains two peptide species; one comigrates with the 186-amino acid residue pancreastatin and the other the 48-residue pancreastatin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2803289     DOI: 10.1016/0006-291x(89)91694-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  The extended granin family: structure, function, and biomedical implications.

Authors:  Alessandro Bartolomucci; Roberta Possenti; Sushil K Mahata; Reiner Fischer-Colbrie; Y Peng Loh; Stephen R J Salton
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

2.  Novel peptides from adrenomedullary chromaffin vesicles.

Authors:  J Sigafoos; W G Chestnut; B M Merrill; L C Taylor; E J Diliberto; O H Viveros
Journal:  J Anat       Date:  1993-10       Impact factor: 2.610

3.  Chromostatin, a chromogranin A-derived bioactive peptide, is present in human pancreatic insulin (beta) cells.

Authors:  Y Cetin; D Aunis; M F Bader; E Galindo; A Jörns; G Bargsten; D Grube
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

Review 4.  The chromogranins A and B: the first 25 years and future perspectives.

Authors:  H Winkler; R Fischer-Colbrie
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.